As new research reveals antidepressants raise the danger of heart attacks, the disturbing cost of this modern addiction
The latest study, by Dr Mark Hamer, a public health researcher at University College London, shows that people on the older drugs — tricyclic antidepressants — are at far higher risk of cardiovascular disease than those taking the newer class of pills, selective serotonin reuptake inhibitors (SSRIs).
But if I were taking SSRIs, I would not be cheered by the findings. Tricyclics were discovered in the Forties and it is only now we have identified these dangerous effects.
Moreover, some SSRI drugs are known to cause serious problems such as stomach bleeding. In addition, the withdrawal symptoms can be so severe that patients may become dependent on them.
Dr Hamer says his findings do not only affect people with depression, because antidepressants are also prescribed to people with back pain, headache, anxiety and sleeping problems.
Last year, according to Dr Hamer’s figures, about 33 million antidepressant prescriptions were dispensed in England.
At some point, surely, there will be no one left to prescribe for. In my view, it’s fast becoming one of the greatest medical scandals of our age.
Tuesday, December 14, 2010
Will we ever wake up to the deadly risks of happy pills?
Friday, October 29, 2010
SSRIs may cause personality change --Archives of General Psychiatry (Dec 2009)
Patients taking a SSRI antidepressant to treat depression may experience changes in their personality separate from the alleviation of depressive symptoms, according to a report in the December 2009 issue of Archives of General Psychiatry.“Patients taking paroxetine reported 6.8 times as much change on neuroticism and 3.5 times as much change on extraversion as placebo patients matched for depression improvement,” the authors write.
The findings provide evidence against a theory known as the state effect hypothesis, which proposes that any personality changes during SSRI treatment occur only as a result of alleviating depressive symptoms, the authors note. Several alternative explanations could be considered. “One possibility is that the biochemical properties of SSRIs directly produce real personality change,” they write. “Furthermore, because neuroticism is an important risk factor that captures much of the genetic vulnerability for major depressive disorder, change in neuroticism (and in neurobiological factors underlying neuroticism) might have contributed to depression improvement.”